Efficacy and acceptability of bowel preparation strategies for inflammatory bowel disease colonoscopy: Systematic review and meta-analysis
Endoscopy International Open · 02.02.2026 · 14 (CP)
DOI: 10.1055/a-2778-9563 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endoscopy International Open, erschienen am 02.02.2026. Verfasst von Gaurav B Nigam und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Gastroenterology and Liver Unit, Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe …. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Patients with inflammatory bowel disease (IBD) frequently undergo colonoscopy, each requiring bowel preparation. European Society of Gastrointestinal Endoscopy (ESGE) 2019 guidelines recommended high- or low-volume polyethylene glycol (PEG)-based bowel prep for IBD patients; however other non-PEG-based preparations (sulphate and picosulphate-based) have now been studied in IBD. We searched CENTRAL, ClinicalTrials.gov, Embase, MEDLINE, and the World Health Organization International Clinical Trials Registry Platform for randomized controlled trials (RCTs) up to December 2024. Primary outcome was bowel prep success; secondary outcomes included tolerability, acceptability, cecal intubation rates (CIR) and safety. Pooled estimates used risk ratio (RR) and GRADE to assess evidence certainty. Ten RCTs (1479 IBD patients) were included. There was no difference in prep success (relative risk [RR] 0.98, 95% confidence interval [CI] 0.88–1.09; I2 = 33%, 2 RCTs; moderate certainty evidence) between 2 L vs. 4 L PEG, but higher acceptability for 2 L (RR 0.69, 95% CI 0.59–0.80; I2 = 18%, 2 RCTs; high certainty evidence). Low-volume non-PEG vs. PEG are probably similar for prep success (RR 0.96, 95% CI 0.90–1.01; I2 = 6%,3 RCTs; moderate certainty evidence). The evidence on tolerability and acceptability was very uncertain. Subgroup analysis revealed comparable effectiveness of picosulphate-based (RR 0.89, 95% CI 0.78–1.01; I2 = 0%,1 RCT) and sulphate-based preps (RR 0.98, 95% CI 0.91–1.05; I2 = 28%, 2 RCTs) compared with low-volume PEG. Safety data were inconsistently reported. High-certainty evidence supports low-volume PEG as comparably successful to high-volume PEG, with higher acceptability. Moderate-certainty evidence indicates similar success between non-PEG and PEG-based preps. Both low-volume PEG and non-PEG-based preps are supported for use in IBD, broadening options beyond current ESGE guidelines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational Gastroenterology and Liver Unit, Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom of Great Britain and Northern Ireland.
- School of Medicine, University of Central Lancashire, Preston, United Kingdom of Great Britain and Northern Ireland.
- Edinburgh Inflammatory Bowel Diseases Unit, Western General Hospital, Edinburgh, United Kingdom of Great Britain and Northern Ireland.
- Institute of Genetics and Cancer, University of Edinburgh Western General Hospital, Edinburgh, United Kingdom of Great Britain and Northern Ireland.
- Wolfson Unit for Endoscopy, St. Mark's Hospital, London, United Kingdom of Great Britain and Northern Ireland.
ORCID-Profile: Gaurav B Nigam, Vassiliki Sinopoulou
Zitieren
APA
Nigam, G. B., Gordon, M., Sinopoulou, V., Tomar, A., Din, S., Vance, M., Wilson, A., East, J. E., & British Society of Gastroenterology Colorectal IBD Surveillance Guideline Development Group (2026). Efficacy and acceptability of bowel preparation strategies for inflammatory bowel disease colonoscopy: Systematic review and meta-analysis. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2778-9563
Vancouver
Nigam GB, Gordon M, Sinopoulou V, Tomar A, Din S, Vance M, et al. Efficacy and acceptability of bowel preparation strategies for inflammatory bowel disease colonoscopy: Systematic review and meta-analysis. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2778-9563
BibTeX
@article{Nigam2026,
author = {Nigam, Gaurav B and Gordon, Morris and Sinopoulou, Vassiliki and Tomar, Anukriti and Din, Shahida and Vance, Margaret and Wilson, Ana and East, James E and British Society of Gastroenterology Colorectal IBD Surveillance Guideline Development Group, British Society of Gastroenterology Colorectal IBD Surveillance Guideline Development Group},
title = {Efficacy and acceptability of bowel preparation strategies for inflammatory bowel disease colonoscopy: Systematic review and meta-analysis},
journal = {Endoscopy International Open},
year = {2026},
volume = {14},
number = {CP},
doi = {10.1055/a-2778-9563}
}
EUVIMED